Hepatitis b core antibody

Hepatitis B core antibody (anti-HBc) is a type of antibody that the immune system produces in response to the core antigen of the Hepatitis B virus (HBV). The presence of anti-HBc indicates either a past or ongoing infection with HBV. This antibody is one of several markers used to diagnose and manage Hepatitis B infection, a major global health concern that affects the liver.

Overview

Hepatitis B is a viral infection that can cause chronic infection, leading to conditions such as cirrhosis and liver cancer. The Hepatitis B virus contains several antigens including the surface antigen (HBsAg), the e antigen (HBeAg), and the core antigen (HBcAg). Correspondingly, the immune response to these antigens includes the production of antibodies: anti-HBs, anti-HBe, and anti-HBc, respectively.

Types of Anti-HBc

There are two types of anti-HBc:

• IgM anti-HBc: This is an immunoglobulin M antibody that appears shortly after the infection with HBV. It is usually a marker of acute or recent infection.
• IgG anti-HBc: This is an immunoglobulin G antibody that appears during the acute phase of hepatitis B and can persist for life. The presence of IgG anti-HBc indicates past exposure to the virus.

Clinical Significance

The detection of anti-HBc is crucial for the diagnosis and management of Hepatitis B infection. It is particularly important in the following contexts:

• Diagnosis of Acute Infection: The presence of IgM anti-HBc, especially in the absence of HBsAg, can indicate an acute HBV infection.
• Window Period: During the window period, when HBsAg has disappeared and anti-HBs has not yet appeared, anti-HBc may be the only serological marker of HBV infection.
• Indication of Past Infection: The presence of IgG anti-HBc in the absence of HBsAg suggests a past HBV infection, with the individual possibly having cleared the virus.
• Occult Hepatitis B Infection: In some cases, individuals may have an occult HBV infection, where HBsAg is not detectable, but HBV DNA can be detected in the liver or serum. Anti-HBc may be the only serological marker indicating such an infection.

Testing for Anti-HBc

Testing for anti-HBc is done using serological assays, which can differentiate between IgM and IgG antibodies. The interpretation of these tests, in conjunction with other HBV serological markers, helps in the accurate diagnosis and management of hepatitis B.

Prevention and Management

Prevention of Hepatitis B involves vaccination, which is effective in preventing HBV infection. Management of individuals with Hepatitis B depends on the nature of their infection (acute or chronic) and may include antiviral therapy and regular monitoring for liver disease progression.

‎

---

Translate: - East Asian 中文, 日本, 한국어, South Asian हिन्दी, தமிழ், తెలుగు, Urdu, ಕನ್ನಡ, Southeast Asian Indonesian, Vietnamese, Thai, မြန်မာဘာသာ, বাংলা
European español, Deutsch, français, Greek, português do Brasil, polski, română, русский, Nederlands, norsk, svenska, suomi, Italian
Middle Eastern & African عربى, Turkish, Persian, Hebrew, Afrikaans, isiZulu, Kiswahili,
Other Bulgarian, Hungarian, Czech, Swedish, മലയാളം, मराठी, ਪੰਜਾਬੀ, ગુજરાતી, Portuguese, Ukrainian